Virginia Retirement Systems’s Aurinia Pharmaceuticals AUPH Stock Holding History

Virginia Retirement Systems’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$1.91M	Sell	119,668 -20,200	-14%	-$286K	0.01%	431
2025 Q3	$1.55M	Buy	139,868 +30,700	+28%	+$335K	0.01%	475
2025 Q2	$925K	Buy	109,168 +9,100	+9%	+$72.9K	0.01%	588
2025 Q1	$805K	Buy	+100,068	New	+$811K	0.01%	617
2023 Q3	$592K	Buy	76,200 +8,900	+13%	+$87K	0.01%	649
2023 Q2	$651K	Buy	67,300 +17,100	+34%	+$177K	0.01%	654
2023 Q1	$550K	Buy	+50,200	New	+$442K	0.01%	712
2022 Q1	$230K	Buy	18,600 +9,400	+102%	+$145K	﹤0.01%	1031
2021 Q4	$210	Buy	+9,200	New	+$218K	﹤0.01%	1046

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Virginia Retirement Systems's AUPH Position: Q4 2025 in Review

Virginia Retirement Systems reduced its Aurinia Pharmaceuticals (AUPH) stake by 14% in Q4 2025, selling an estimated $286K and leaving 119,668 shares worth $1.91M. The position accounts for 0.01% of the portfolio, ranked #431.

Virginia Retirement Systems first reported a position in AUPH in Q4 2021 and has held it in 9 quarters since. 255 funds tracked by Wall St. Rank hold AUPH as of Q4 2025.

Virginia Retirement Systems held 119,668 shares of Aurinia Pharmaceuticals worth $1.91M as of Q4 2025.
Virginia Retirement Systems sold 20,200 Aurinia Pharmaceuticals shares in Q4 2025, an estimated $286K.
Aurinia Pharmaceuticals made up 0.01% of Virginia Retirement Systems's portfolio in Q4 2025, its #431 holding.
Virginia Retirement Systems first reported a position in Aurinia Pharmaceuticals in Q4 2021 and has held it in 9 quarters since.
255 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2025.

Based on Virginia Retirement Systems's 13F filing for Q4 2025, filed 4 Feb 2026.